Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "subsidiary"
Home
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?
Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous injections to subcutaneous...
03/17/2026, 01:44 ET
Hanmi Pharmaceutical, CEO Park Jae-hyun Steps Down: Hwang Sang-yeon Appointed as New CEO Candidate
Hanmi Science is replacing CEO Park Jae-hyun of its subsidiary Hanmi Pharmaceutical and forming a new board of directors to stabilize management...
03/17/2026, 01:44 ET
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug...
03/04/2026, 01:23 ET
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
02/18/2026, 04:26 ET
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
02/05/2026, 04:06 ET
Celltrion "Asthma Drug 'Omrilclo' Captures 60% Market Share in Spain"
Celltrion announced on the 4th that its chronic spontaneous urticaria and allergic asthma treatment, 'Omrilclo ', is...
02/05/2026, 04:06 ET
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine
SK Bioscience is accelerating the development of the next-generation Ebola vaccine with funding support from the...
01/23/2026, 03:23 ET
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?
Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development...
01/22/2026, 19:11 ET
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
01/08/2026, 17:50 ET
Bukwang Pharmaceutical Selected as Final Acquirer of Korea Union Pharmaceutical... Production Capacity Increased by 30%
Bukwang Pharmaceutical announced on the 5th that it has been selected as the final acquirer of Korea Union...
01/04/2026, 18:52 ET
Previous
1
2
3
4
Next